Novo Tellus Capital Partners’ investment into Amsino and subsequent exit of Amsino’s investors

Rajah & Tann Singapore acted for Amsino Medical Group Company Limited in a substantial investment into Amsino by private equity firm Novo Tellus Capital Partners, and the subsequent exit of Amsino’s investors Jiangsu Yuwell Medical Equipment & Supply Company Limited and Jiangsu Yuwell Technology Development Company Limited via a share buyback carried out by Amsino. Amsino is a global designer and manufacturer medical devices and consumables, which are distributed to hospitals and other healthcare institutions worldwide, with key markets in the US and the PRC. Novo Tellus is a private equity firm specialising in long-term investments in the global supply chain. Partner Tan Mui Hui led the transaction.

Meet Our Team

Singapore
+65 6232 0191

Meet Our Team

Singapore
+65 6232 0191

Rajah & Tann Asia is a network of legal practices based in Asia.

Member firms are independently constituted and regulated in accordance with relevant local legal requirements. Services provided by a member firm are governed by the terms of engagement between the member firm and the client.

This website is solely intended to provide general information and does not provide any advice or create any relationship, whether legally binding or otherwise. Rajah & Tann Asia and its member firms do not accept, and fully disclaim, responsibility for any loss or damage which may result from accessing or relying on this website.

© 2024 Rajah & Tann Asia. All Rights Reserved. All trademarks are property of their respective owners.